MET and hepatocellular carcinoma: However, c-MET alone cannot induce HCC in mice but requires the presence of additional molecular events, such as AKT overexpression, β-Catenin activation, or loss of the PTEN oncosuppressor to drive liver malignant transformation [12–14].